Cold Cap May Prevent Chemo Hair Loss

A system that would keep a patient’s scalp cool during chemotherapy may prevent hair loss for millions of people being treated for breast cancer, a new study suggests.

More than half the women enrolled in the study funded by Paxman Cooling, the maker of the Orbis Paxman Hair Loss Prevention System (OPHLPS) or “cold caps”.

“In Europe, scalp-cooling technology has helped many patients avoid hair loss and maintain their quality of life, and there is a great deal of interest in scalp-cooling in the United States,” said lead report author, Julie Rani Nangia MD, an assistant professor at the Lester and Sue Smith Breast Center and Baylor College of Medicine.

Nangia and her team enrolled 235 women with stage 1 or stage 2 breast cancer planning to undergo at least four cycles of chemotherapy. More than 50 of patients of patients using the cooling caps had preserved their hair compared to patients not using the caps.

Breast cancer is diagnosed to more than 250,000 people a year in the United States, according to the CDC. Nangia said preventing hair loss may improve a patient’s emotional well-being and maintain a degree of privacy.

Nangia said there are concerns over cost and potential metastasis to the scalp has slowed similar products from becoming popular in the United States.

In 2015, the FDA gave clearance to scalp-cooling system made by Dignitana Inc., called the DigniCap. Paxman is seeking U.S. Food and Drug Administration (FDA) clearance on OPHLPS.

Sourced from Web MD